
NASDAQHealthcareMedical - Devices
Latest quote
$18.4673
+$0.0273 · +0.15%
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
Regular session
$18.4673
+$0.0273 · +0.15%
Regular session · ET · Market data may be delayed.
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
Day range
Current $18.4673
52-week range
Current $18.4673
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
65
Undervalued
Sentiment
45
Mixed
Risk
45
Elevated Risk
Momentum
43
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: Medical and Industrial. Within the Medical segment, Varex provides a comprehensive range of X-ray imaging components. These include essential hardware like X-ray tubes, digital detectors, and high-voltage connectors, alongside sophisticated software solutions for image processing, 3D reconstruction, and computer-aided diagnostics. The segment also supplies critical ancillary devices such as collimators, generators, and automatic exposure control mechanisms. These medical products serve a wide spectrum of applications, from general diagnostic imaging like radiography and fluoroscopy, to specialized areas such as mammography, computed tomography (CT), cardiac procedures, dental imaging, and surgical applications. They are also vital for radiation therapy, oncology, and advanced computer-aided detection systems. The Industrial segment focuses on providing X-ray technology for security and industrial inspection. Its offerings include Linatron X-ray accelerators, X-ray tubes, digital detectors, and high-voltage connectors. These components are crucial for diverse applications such as airport security scanning, cargo screening at border crossings, and nondestructive testing across various industries. Varex distributes its products through multiple channels, including direct sales to end-users, partnerships with imaging system Original Equipment Manufacturers (OEMs), independent service providers, and a network of distributors. With a significant global footprint, the company maintains operations across North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Established in 2016, Varex Imaging Corporation is headquartered in Salt Lake City, Utah.
Day range
Current $18.4673
52-week range
Current $18.4673
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 844.6M USD | 811M USD | 893.4M USD | 859.4M USD | 818.1M USD |
| Cost of goods sold | 554.1M USD | 554.1M USD | 603.1M USD | 575.9M USD | 546.6M USD |
| Gross profit | 290.5M USD | 256.9M USD | 290.3M USD | 283.5M USD | 271.5M USD |
| Research and development | 91.1M USD | 87M USD | 84.8M USD | 77M USD | 71.9M USD |
| Selling, general, and administrative | 133.3M USD | 137.8M USD | 128.4M USD | 118.3M USD | 125.5M USD |
| Operating expenses | 318.3M USD | 224.8M USD | 213.2M USD | 195.3M USD | 197.4M USD |
| Interest income | 8.5M USD | 7.3M USD | 3.7M USD | 400K USD | 100K USD |
| Interest expense | 35.5M USD | 31.1M USD | 29.3M USD | 41M USD | 43.4M USD |
| Depreciation and amortization | 27.2M USD | 31.1M USD | 33.2M USD | 33.6M USD | 37.3M USD |
| Operating income | −27.8M USD | 32.1M USD | 77.1M USD | 88.2M USD | 74.1M USD |
| Net income | −70.3M USD | −47.7M USD | 47.4M USD | 30.3M USD | 17.4M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI24.88M0.00%2.3T USD0.03%$380.13-0.24%
iShares Russell 2000 ETFIWM20.43M0.03%78.56B USD0.19%$275.99-0.62%
Vanguard Extended Market ETFVXF9M0.01%95.4B USD0.05%$232.16-0.57%
Fidelity Enhanced Small Cap ETFFESM7.6M0.12%6.41B USD0.28%$44.955-0.59%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV6.14M0.02%26.69B USD0.33%$37.825+0.08%
Vanguard Russell 2000 ETFVTWO4.5M0.02%18B USD0.06%$111.46-0.67%
Schwab U.S. Small-Cap ETFSCHA4.11M0.02%21.7B USD0.03%$32.445-0.51%
iShares U.S. Medical Devices ETFIHI3.86M0.11%3.5B USD0.37%$50.59-0.71%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Fidelity Enhanced Small Cap ETFFESM
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Russell 2000 ETFVTWO
Schwab U.S. Small-Cap ETFSCHA
iShares U.S. Medical Devices ETFIHIAI-generated and delayed market data for informational and educational purposes only. Not investment advice.